Viral Infections
RSSArticles
-
Nirmatrelvir and Ritonavir Tablets (Paxlovid)
The FDA has issued an emergency use authorization for the first oral regimen for the treatment of COVID-19.
-
FDA Authorizes Oral Antiviral for COVID-19
Clinicians add another valuable tool to their armamentarium.
-
First Injectable Pre-Exposure Prophylaxis Receives FDA Approval
Researchers hope this long-acting solution every will boost PrEP adherence rates among those at risk for contracting HIV.
-
Biden to Send Military Aid to Struggling Hospitals, Millions of COVID-19 Tests to American Homes
The White House has announced its plan to respond to the omicron variant ahead of a possible winter case surge.
-
AAP Recommends Routine HIV Screening, Prevention for All Teens, At-Risk Youth
The organization advises pediatricians to create safe spaces that allow frank discussions of sensitive topics.
-
Analysts Suggest U.S. COVID-19 Vaccination Program Prevented Millions of Hospitalizations, Deaths
The pandemic has taken a heavy toll, but the damage could be so much worse without vaccines.
-
Pandemic Emergency Funds Spiked Healthcare Spending
Data show eye-popping healthcare expenditure growth for 2020, driven by federal paycheck protection, provider assistance, vaccine development, and virus testing.
-
Infectious Disease Alert Updates
Candida auris Outbreak in Southern California; Healthcare Worker Vaccine Mandates
-
Looking Back, COVID-19 Vaccination Woes Were Predictable
Efficacy, protection duration, side effects, and FDA approval factored into decisions about choosing a COVID-19 vaccine.
-
Fluvoxamine Reduces the Risk for Hospitalization from COVID-19
Researchers found fluvoxamine (100 mg twice a day for 10 days) lowered the risk for hospitalization among high-risk outpatients diagnosed with COVID-19.